Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sonnet Biotherapeutics Holdings Inc (SONN)

2.555   -0.025 (-0.97%) 11-27 12:48
Open: 2.56 Pre. Close: 2.58
High: 2.57 Low: 2.48
Volume: 408,087 Market Cap: 36M
Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.723 - 2.737 2.737 - 2.75
Low: 2.483 - 2.499 2.499 - 2.514
Close: 2.55 - 2.576 2.576 - 2.601

Technical analysis

as of: 2020-11-27 12:24:37 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.10     One year: 3.35
Support: Support1: 2.30    Support2: 1.91
Resistance: Resistance1: 2.65    Resistance2: 2.87
Pivot: 2.48
Moving Average: MA(5): 2.51     MA(20): 2.51
MA(100): 2.77     MA(250): 7.30
MACD: MACD(12,26): -0.03     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 66.85     %D(3): 57.76
RSI: RSI(14): 50.13
52-week: High: 54.60  Low: 2.23  Change(%): -85.6
Average Vol(K): 3-Month: 61883  10-Days: 85702

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SONN has closed below upper band by 23.5%. Bollinger Bands are 69.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to SONN's normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 27 Nov 2020
Is Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) a Suitable Stock for New Investors Now? - Stocks Register

Thu, 26 Nov 2020
Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) stock market valuation reached $35.89 million - BOV News

Wed, 25 Nov 2020
Sonnet BioTherapeutics Holdings Inc. (SONN) distance from 20-day Simple moving Average is 2.94%: What to Expect? - The InvestChronicle

Sat, 14 Nov 2020
Is Sonnet BioTherapeutics Holdings, Inc.(NASDAQ:SONN) Stock Good For Medium-Term Investing? - Stocks Register

Fri, 09 Oct 2020
Sonnet BioTherapeutics Holdings Inc. [SONN] is -80.64% lower this YTD. Is it still time to buy? - The DBT News

Tue, 25 Aug 2020
Sonnet BioTherapeutics Holdings Inc. [SONN] is -74.58% lower this YTD. Is it still time to buy? - The DBT News

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.